唐传生物科技

Tangchuan Biotechnology is a specialized life sciences company focused on the research, development, and industrialization of rare sugars and functional sugar alcohols, most notably L-arabinose. The company utilizes proprietary biological extraction and enzymatic conversion technologies to produce high-purity functional sweeteners that act as metabolic regulators. Their flagship product, L-arabinose, is a natural sucrase inhibitor that reduces the glycemic index of sucrose-containing foods by blocking glucose absorption. Tangchuan serves the global pharmaceutical, nutraceutical, and food industries, providing ingredients and finished products aimed at managing metabolic health issues such as diabetes and obesity. With major manufacturing bases in Xiamen and Jiangsu, the company is a pioneer in the commercial-scale production of rare sugars in China.